ABSTRACT: Application of a GABA (gamma-aminobutyric acid) type A receptor antagonist through a microdialysis probe into the forelimb primary motor cortex (MI) of ketamine anesthetized rats induced the appearance of paroxysmal field potentials recorded in the supragranular layers of the MI and concomitant electromyographic (EMO) activity in the contralateral forelimb. ApplicaUon of a nonNMDA (N-methyI-D-aspartate) glutamate receptor antagonist in conjunction with the GABA type A receptor antagonist completely blocked the paroxysmal field potentials and the EMG ac'dvity of the contralateral forelimb, while a NMDA receptor antagonist had no effect. The results indicate that the spread of activity within the primary motor cortex and the motor cortex output are mediated by nonNMDA receptors.
INTRODUCTION
During several behavioral states (i.e., visual stimulus processing [13] , etc.) neuronal activity in the cerebral neocortex is highly synchronized. Moreover, cortical synchronized activity is observable both in normal behavioral states and in pathologic states [19] (i.e., epileptic seizures) and the initiation and maintenance of some of these synchronized activities seems to be due to mechanisms intrinsic to the cortex [6, 9] .
It has been shown that a network of intrinsically bursting cells [10] in the middle cortical layers can initiate and coordinate synchronized excitation in the cerebral neocortex [6, 9] . These cells seem to be both necessary and sufficient to initiate synchronized activity in the cortex. It has been suggested that in pathologic states such as epilepsy, these neurons could synchronize epileptiform activity [9] . This is in accordance with the fact that pharmacological blockade of GABA type A receptors leads to the spread of synchronized activity within the cortex [5, 6, 8, 14] , which resembles that observed during the seizures of epilepsy [14] .
As indicated above, there has been extensive work on the study of the initiation of synchronized neuronal activity in the cortex induced by GABA type A receptor blockade. However, the study of the suppression and blockade of synchronized activity has been less extensive. The possibility of blocking cortical synchronization is important because it may serve to control several pathologic states related with this activity, as well as further serve to reveal the mechanisms responsible for synchronized neuronal activity in the cortex. It has been proposed that during disinhibition paroxysmal field potentials, which are the result of synchronized neuronal bursting [9, 14] , occur due to the spread of the activity generated by intrinsically bursting neurons of layers IV and upper V, to the rest of the cortex. This synchronized activity would be transmitted through the extensive intracortical axon collaterals of the intrinsically bursting cells [7, 11] , and therefore the activity would spread throughout the cortex. If this is the case, pharmacological blockade of the specific receptors involved in the spread of this activity would eliminate the paroxysmal field potentials. It is accepted that the neurotransmitter that mediates the excitatory input between pyramidal cells is glutamate [12] . Thus, the receptor mediating the excitatory activity upon the pyramidal cells could be of the N-methyl-D-aspartate (NMDA) type or of the nonNMDA type [ 18] . We have recently shown that forelimb motor activity induced by cortical disinhibition is eliminated by nonNMDA receptor blockade [3] . In the present study, we addressed the question of what receptor type would mediate the spread of spontaneous paroxysmal field potentials to determine if it is the same as the one mediating the observed motor output in the presence of disinhibition. We also investigated if the activation of other glutamate receptors (i.e., those not responsible for the spread of paroxysmal field potentials) would unmask additional mechanisms for motor cortex output and the spread of synchronized excitation.
MATERIALS AND METHODS
The experiments were performed in male Wistar rats (250-300 g.) Rats were anesthetized with ketamine (100 mg/kg). Stainless steel insulated wires with 1-mm uninsulated tips were implanted into individual muscles of the forearm. The skin over the forearm was incised and electrodes were inserted into the muscle about 2 mm apart, and the skin was sutured closed. The correct placement of the electrodes in the muscle was verified by observing the movement evoked by stimulating electrically EMG indicates if EMG activity was observed in the contralateral forelimb after infusion of the drug combination.
through the implanted wires (200/as pulses, 0.5 mA). The animal was then placed in a stereotaxic apparatus and a craniotomy that extended from bregma to 2 mm anterior and from 1 to 3 mm lateral from the midline was performed in the hemisphere contralateral to the forelimb with the implanted electrodes. The cerebral neocortex was exposed and a dialysis probe was inserted into the cortex. The dialysis probe was of a concentric design [ 1 ] using a cuprophan hollow dialysis membrane. The dialysis membrane extended 2 mm into the brain from the pia to perfuse the cerebral neocortex. An electrode placed adjacent to the dialysis membrane served to verify that the area with the implanted dialysis probe was the forelimb primary motor cortex, by applying current trains (100 ms of 300 Hz, 200 /as pulse duration monophasic cathodal pulses of 30/aA) that elicited movements of the contralateral forelimb. Based on previously conducted forelimb motor cortex maps and on microstimulation of several sites, the dialysis probe was placed in a location determined to be near the center point of the forelimb representation. A Platinum-Iridium glass insulated microelectrode (2-7 MOhms measured at 1 kHz) was lowered between 0.5-0.8 mm into the cerebral neocortex and adjacent to the dialysis probe. The electromyographic (EMG) signals were differentially amplified (Grass P15) with the bandpass set at 0.3-3 kHz. Extracellular field potentials (EFP) were recorded in the cortex through the PtIr microelectrode. Signals were differentially amplified (Grass P15) with the bandpass set at 0.001-3 kHz. EMG and EFP signals were monitored on an oscilloscope, and data was recorded with a computer. The dialysis probe was perfused at a constant rate of 2/al/min with Krebs Ringer bicarbonate and was left in place for at least 60 min prior to the initiation of each experiment. After this period, each rat was perfused with a drug or drug combination for 5 rain (see Table 1 ). The substances used in the present study were: bicuculline methobromide (BIC, 100/aM, 1 mM), DL-2-amino-5-phosphonovaleric acid (APV; 1, 2.5, 5 mM), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 100 #M, 1 mM), glutamate (GLU, 1 mM, 2 mM). Gutamate was substituted with: quisqualic acid (QA, 2mM), N-methyl-D-aspartate (NMDA, 2 mM) or kainic acid (KA, 2 mM). Different concentrations of these drug combinations were also tested. These products were also all injected alone. Bicuculline, APV, CNQX, KA, QA and NMDA were purchased from Cambridge Research Biochemicals, and glutamate was purchased from Sigma. During the period of perfusion and up to 60 min after perfusion of the test substances, the EFP and EMG activity was monitored through an oscilloscope, and samples were recollected at a sample rate of 1 kHz through a computer. A minimum of ten samples were collected for each test substance combination. Each experiment was repeated at least three times. A total of 25 rats were used in these experiments.
RESULTS
The application of the GABA type A receptor antagonist (bicuculline) into the forelimb MI resulted in the occurrence of spontaneous paroxysmal field potentials in the supragranular layers of the forelimb MI and concomitant EMG activity in the contralateral forelimb (Fig. 1) , which when sufficiently large reflected a clearly observable forelimb movement. The rate of the spontaneous paroxysmal field potentials and concomitant EMG activity varied depending on the degree of cortical disinhibition (Fig. 1 ). This was evident by monitoring conjointly the EFP and concomitant EMG activity as bicuculline was infused through the dialysis probe. As disinhibition increased, the EFPs and EMG signals decreased in frequency and increased in amplitude and duration. Doses as small as 100/aM bicuculline infused for 5 min elicited small paroxysmal field potentials and concomitant EMG activity (similar to Fig. lb or 3b) . Figure 3 shows recovery from paroxysmal field potentials and EMG activity 80 min after infusion with bicuculline (1 mM) for 5 min (Fig. 3a) .
In order to test if blocking NMDA receptors would affect the paroxysmal field potentials and concomitant EMG activity induced by bicuculline, this drug was infused conjointly with an NMDA receptor antagonist (APV). Application of APV (1 raM, 2.5 mM or 5 mM) did not block the spontaneous paroxysmal field potentials or the EMG activity elicited by bicuculline (Fig. 2a) .
In order to test if blocking nonNMDA receptors would block the paroxysmal field potentials and concomitant EMG activity induced by bicuculline, this drug was infused conjointely with a nonNMDA receptor antagonist. Application of a nonNMDA receptor antagonist (CNQX; 1 mM)), which blocks transmission through the quisqualate and kainate receptors, completely abolished the spontaneous paroxysmal field potentials and concomitant EMG activity elicited by bicuculline (Fig. 2b) . After the conjoint application of bicuculline and CNQX, no paroxysmal field potentials or EMG activity were observed. This effect was observed at all doses of bicuclline and CNQX tested. Doses of 100/aM bicuculline infused for 5 min elicit small paroxysmal field potentials and concomitant EMG activity (similar to Fig. lb  or 3b) , which are totally blocked by a 100 #M dose of CNQX. This indicates that the drug effects were specific to their primary receptor target. The effect of CNQX upon bicuculline induced field potentials was also reversible since application of bicuculline alone (1 mM or 100 #M) 65 min after conjoint application of CNQX and bicuculline induces the appearance of paroxysmal field potentials and EMG activity (Fig. 3b) .
In order to test if activation of glutamate receptors not blocked by CNQX would unmask a subsequent mechanism for motor output and synchronized excitation in the presence of disinhibition, we applied different receptor agonists in the presence of nonNMDA and GABA type A receptor blockade. When bicu- culline and CNQX were applied with a dose of glutamate (normaUy a dose equal or twice the dose of CNQX and bicuculline was used; i.e., 2 mM), the blocking effect of CNQX upon the bicuculline induced EMG activity was abolished and EMG activity reappeared, but no paroxysmal field potentials were observed (Fig. 2c) . This effect was further investigated by substituting glutamate with the specific receptor agonists on which glutamate may act. Thus, the application of QA or KA conjointly with BicucuUine and CNQX did not induce the appearance of paroxysmal field potentials or electromiographic activity. However, the application of NMDA (2 mM) conjointly with bicuculline and CNQX induced the appearance of electromiographic activity but did not produce the appearance of paroxysmal field potentials (similar to Fig. 2c ). The effect of glutamate or NMDA upon EMG activity in the presence of CNQX and bicuculline was also reversible since shortly after infusion of this drug combination the effect upon EMG activity was reversed (Fig. 3c) . The reversibility of this effect was more rapid if glutamate (10 re_in) was infused compared to infusion of NMDA (35 rain). Finally, the application of the same dose of glutamate or NMDA alone does not induce paroxysmal field potentials or EMG activity (not shown, but similar to Fig. la ). An important issue of the effects observed is the spread of these drugs. In the present study there is clear evidence that the drugs were having a limited spread. This is indicated by the fact that if the drugs were spreading large distances, we would be able to observe movements of other body parts (i.e., vibrissae, hindlimb), in addition to the forelimb, due to the spread of the drugs (i.e., bicucuUine) to other motor representations. However, this was not the case, and it indicates that the effects of the drugs at the concentrations and conditions of infusion used was limited by a small spread (i.e., less than 1 mm) since the size of the forelimb representation is 2 mm or less in the mediolateral dimension [4] . Another possibility is that the drugs produced their effects by acting in the striatum; however, this is unlikely and probably not relevant since bicuculline infused into this area does not induce forelimb movements, nor does it induce paroxysmal field potentials in the cortex (unpublished observations). Another important issue concerns the specificity of the drug actions. Were the drugs only acting on their primary receptor targets? This point has been addressed for CNQX by using a lower dose (100 #M), which under the conditions of infusion used--microdialysis; actual dose affecting the tissue is < 10% considering the rate of recovery through the dialysis membrane; see ref. 1--should not reach concentration levels that would affect other than the primary target of the drug as determined in slices [15] . We also addressed the issue of specificity in the case of NMDA restoring the EMG activity by using agonists of the other glutamate receptor types, and since none of them was effective, it indicated that glutamate and NMDA 542 CASTRO-ALAMANCOS AND BORRELL were acting specifically on NMDA glutamate receptors. Therefore, it seems that the drugs that produced an effect were acting upon their primary targets only.
DISCUSSION
The results show that disinhibition produced by blocking the GABA type A receptors in MI induces the appearance of spontaneous paroxysmal field potentials measured in the supragranular layers of the cerebral neocortex and concomitant EMG activity in the body part represented by this MI area. This effect is not affected by the application of a NMDA receptor antagonist, while the application of a nonNMDA receptor antagonist completely blocks the paroxysmal field potentials measured in the supragranular layers and concomitant EMG activity. Finally, the results also show that glutamate is able to restore the EMG activity in the presence of nonNMDA and GABA type A receptor blockade but does not restore the spontaneous paroxysmal field potentials in the supragranular layers. Since the effect of glutamate in the presence of GABA type A and nonNMDA receptor blockade is mimicked by NMDA, and not by quisqualic acid or kainic acid, it is suggested that under these conditions motor cortex output can be restored by activation of NMDA receptors.
The present study shows that synchronized activity and motor output within the cortex are mediated by nonNMDA receptors. This result is in accordance with the existing evidence of a larger contribution of nonNMDA receptors in excitatory synaptic potentials within the cortex [16] . Recent work agrees that NMDA receptors have a small but consistent contribution to synaptic transmission in the cortex, and the present results indicate that this is the case and that blocking this contribution does not eliminate either motor output or the spread of excitation within the cortex. The results also show that NMDA receptor activation in the presence of gabaergic type A and nonNMDA receptors blockade is able to restore the motor cortex output but not the synchronized excitation in the MI. The possible mechanisms mediating this effect are currently unclear, but several data suggest a possible interpretation. Since APV is not able to block the paroxysmal field potentials or EMG activity induced by disinhibition, it seems that this activity is very effectively mediated through nonNMDA receptors. NMDA receptor activation is not necessary to induce or facilitate synchronized excitation or motor cortex output. However, NMDA receptor activation seems to be sufficient to induce motor cortex output in the presence of disinhibition and nonNMDA receptor blockade, and this may be due to the fact that in the presence of disinhibition the membrane potential of cortical cells (layer V corticospinal cells) may become more positive and near threshold. During depolarization NMDA receptors have been shown to play a similar contribution than nonNMDA receptors in mediating synaptic excitatory potentials in the cortex [16] . It seems that NMDA receptor activation in the presence of disinhibition may be sufficient but not necessary to induce motor cortex output in the MI. The balance between NMDA, nonNMDA and GABA type A receptors may be essential in mediating processes, which have been proposed to be the consequence of the reorganization of the intracortical networks responsible for synchronized excitation and motor cortex output. These may include reorganizational processes mediating recovery of function after cortical damage [2] and the learning dependent changes in motor cortical representations that occur throughout life [4, 17] .
In conclusion, the results show that disinhibition in the MI induces the appearance of spontaneous paroxysmal field potentials in the cerebral neocortex and concomitant EMG activity in 
